RecruitingNot applicableNCT06735976
Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations
Studying Pulmonary arteriovenous malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of North Carolina, Chapel Hill
- Principal Investigator
- Nima Kokabi, MDUniversity of North Carolina, Chapel Hill
- Intervention
- PAVM Embolization(device)
- Enrollment
- 30 target
- Eligibility
- 14 years · All sexes
- Timeline
- 2024 – 2029
Study locations (1)
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Collaborators
Okami Medical, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06735976 on ClinicalTrials.gov